OTTAWA --
Moderna mentioned on Thursday Canada licensed its COVID-19 vaccine to be used in youngsters between 6 and 11 years of age.
The vaccine, branded Spikevax, was just lately cleared to be used amongst youngsters in the identical age group in Australia and the European Union.
Moderna final 12 months mentioned its two-dose vaccine generated virus-neutralizing antibodies in youngsters aged 6-11 years and security was similar to that seen in medical trials of adolescents and adults.
The vaccine, based mostly on messenger RNA (mRNA) know-how, is authorized in the US for individuals aged 18 and above. The corporate is awaiting a call from U.S. regulators on using its vaccine for youngsters aged 12 via 17 years.
Rival Pfizer's shot is cleared in the US for youngsters as younger as 5 years.
Canada in August had licensed Moderna's vaccine for adolescents
Post a Comment